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Abstract 26 
Objectives: To compare red cell distribution width (RDW) between dogs with different 27 
causes of pulmonary hypertension (PH) and a control dog population to determine whether 28 
RDW was correlated with severity of PH as measured by echocardiography. A further aim 29 
was to determine the prognostic significance of increased RDW for dogs with PH.   30 
Animals: Forty-four client-owned dogs with PH and 79 control dogs presented to a single 31 
tertiary referral institution. 32 
Methods: Signalment, clinical pathological and echocardiographic data were obtained 33 
retrospectively from the medical records of dogs with PH, and RDW measured on a Cell-Dyn 34 
3500 was compared between dogs with pre- and post-capillary PH and a control population.  35 
Referring veterinary surgeons were contacted for follow-up information and Kaplan-Meier 36 
analysis was conducted to investigate differences in survival time between affected dogs with 37 
different RDW values.   38 
Results: The RDW was significantly greater in dogs with pre-capillary PH compared to 39 
control dogs. There was no difference in median survival times between dogs with PH 40 
divided according to RDW values. The RDW was positively correlated with mean 41 
corpuscular volume and haematocrit in dogs with PH, but did not correlate with 42 
echocardiographic variables.      43 
Conclusions: An association was found between dogs with PH and increased RDW; however 44 
there was considerable overlap in values between control dogs and dogs with PH. The RDW 45 
was not associated with survival in this study.   46 
 47 
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 50 
Abbreviations 51 
cTnI cardiac troponin I 
IQR 
inter-quartile range 
LA:Ao 
ratio of left atrial to aortic root diameter 
NT-proBNP 
N-terminal pro-brain natriuretic peptide 
PH pulmonary hypertension 
PR pulmonic regurgitation 
PRPG peak diastolic pulmonic regurgitant pressure 
gradient 
RDW red cell distribution width 
ROC receiver operator characteristic 
TR tricuspid regurgitation 
TRPG peak systolic tricuspid regurgitant pressure 
gradient 
 52 
 53 
  54 
Introduction 55 
Red cell distribution width (RDW) is a measure of degree of anisocytosis in the erythrocyte 56 
population and is expressed as the coefficient of variation of the erythrocyte size distribution 57 
data.a The RDW is regularly reported by modern haematology analysers.1-3 A number of 58 
recent publications have identified RDW as an independent predictor of outcome in a wide 59 
range of different human diseases.4-9 The ability of RDW to predict outcome independently in 60 
human patients with pre- and post-capillary pulmonary hypertension (PH) has been widely 61 
investigated and found to be clinically useful.10-15 62 
 Pulmonary hypertension is recognised in dogs with increased frequency due to 63 
growing access to Doppler echocardiography enabling non-invasive measurement of 64 
tricuspid and pulmonic insufficiency jet velocities, which are surrogate measures of systolic 65 
and diastolic pulmonary artery pressure gradients, respectively.16 Pulmonary hypertension 66 
can be classified as pre-capillary or post-capillary, or a five point classification system can be 67 
used based on the pathological process underlying the PH. These five categories of PH 68 
include pulmonary arterial hypertension associated with parasite infestation or congenital 69 
systemic-to-pulmonary shunts, PH due to left-sided cardiac disease, PH related to diseases of 70 
the pulmonary parenchyma, PH resulting from thromboembolic events involving the 71 
pulmonary vasculature, and miscellaneous causes.17,18  72 
 A number of studies have explored the diagnostic utility of circulating biomarkers, 73 
including natriuretic peptides and cardiac troponin I (cTnI), in dogs with pre- and post-74 
capillary PH.19-22 To date, the relationship between PH and RDW in dogs has been described 75 
in a single study, which suggested that RDW was increased in dogs with pre-capillary PH 76 
when compared to controls.b There remains a paucity of information regarding the diagnostic 77 
and prognostic utility of RDW in dogs with PH due to a variety of causes.  78 
 79 
 The aims of the study were to determine if RDW differed between dogs with pre- and 80 
post-capillary PH and clinically normal dogs, to ascertain if RDW is associated with severity 81 
of PH determined by Doppler echocardiography, and to evaluate the prognostic value of a 82 
single measurement of RDW at time of presentation in dogs with PH.  83 
 84 
Animals, materials and methods 85 
Selection of cases and controls   86 
The computerised medical record system of a tertiary referral hospital was searched to 87 
identify dogs that had a diagnosis of PH between February 2008 and February 2012. Cases 88 
were selected if a complete medical history and physical examination were available, routine 89 
diagnostic samples were submitted for complete haematology and serum biochemistry 90 
analysis at the same visit, and a full echocardiographic examination was also performed to 91 
confirm the presence of PH. Other diagnostic procedures were instituted based on the 92 
presenting signs and initial assessment. Cases were excluded if the haematocrit value was 93 
below the lower reference limit, if the complete medical record was not available for review, 94 
or if the dog had concurrent systemic disease including cancer, diabetes mellitus, 95 
portosystemic shunt or had undergone surgical procedures or blood transfusion within the 96 
previous 90 days.   97 
 A control group of dogs was also identified, that was comprised of blood donor dogs 98 
and clinical cases treated at the same institution over the same time period. All dogs 99 
underwent complete physical examination and had blood samples submitted for complete 100 
haematology and serum biochemistry analysis either as part of clinical investigations or prior 101 
to blood donation. Blood donors were included if they had not donated blood for at least 90 102 
days prior to submission of blood samples, if there were no abnormalities on physical 103 
examination and no reported health problems, and if blood sample results were unremarkable. 104 
Blood sample results were considered to be unremarkable if the values for all parameters 105 
were within the laboratory reference intervals, or, if outside these intervals, were judged to be 106 
clinically unimportant by two of the authors (DJC, AH). Clinical cases were included if their 107 
clinical signs were not associated with systemic inflammatory or infectious diseases and if 108 
their blood sample findings were unremarkable, as described above. These cases largely 109 
consisted of dogs presented for investigation of orthopaedic or ophthalmological problems.  110 
Clinical cases were excluded if they had undergone surgical procedures or blood transfusion 111 
prior to sampling or had clinical or historical evidence of haemorrhage within the previous 90 112 
days.   113 
 114 
Data collection   115 
Data relating to signalment, clinical presentation, and blood sample results were extracted 116 
from the medical records of each case with PH. Referring veterinary surgeons were contacted 117 
by telephone to obtain follow-up data in January 2014 using a protocol that conformed to 118 
good research practice policy at the institution. The endpoint of the study was death, 119 
categorised as cardiorespiratory or non-cardiac. Cardiorespiratory causes included death or 120 
euthanasia due to clinical signs of congestive heart failure, worsening breathlessness, signs 121 
attributable to polycythaemia or sudden death unrelated to known systemic disease or trauma. 122 
Non-cardiac causes were death or euthanasia following clinical signs not attributable to 123 
cardiorespiratory disease (e.g. immune mediated disease, trauma, and neoplasia other than 124 
pulmonary neoplasia). The end of the study period was February 2014. 125 
 126 
Red cell distribution width  127 
The RDW was measured using a single haematological analysera previously validated for 128 
canine haematology as part of a routine haematology analysisc as previously reported.3 129 
Erythrocyte histograms, blood smears, or blood smear reports were reviewed where available, 130 
and individuals were excluded if histogram separation appeared poor or if platelet clumps 131 
were identified. Blood samples were processed within 24 hours of collection at the same site 132 
as the hospital, and serum biochemical analyses were conducted with the same analyser in all 133 
cases.d   134 
 135 
Echocardiography  136 
All patients with PH underwent complete echocardiographic examinatione and all 137 
echocardiographic measurements were made off-linef by one observer (DJC). Standard two-138 
dimensional views were obtained23 and Doppler studies were also completed using a 2.5-5.5 139 
or 5.5-7.5 MHz transducer. Dogs were positioned in left and right lateral recumbency with 140 
echocardiography performed on the dependent side. For Doppler evaluation, the right- or left-141 
sided view that allowed for optimal alignment of the continuous wave Doppler interrogation 142 
beam through the regurgitant flow across the tricuspid valve and/or pulmonic valve was used 143 
to measure instantaneous peak systolic tricuspid regurgitation (TR) or peak diastolic 144 
pulmonic regurgitation (PR) velocities. Pulmonic stenosis was excluded by confirming 145 
normal valvular anatomy and mobility on two-dimensional echocardiography and identifying 146 
laminar pulmonic flow profile via pulsed-wave Doppler echocardiography with peak 147 
pulmonary artery flow velocities less than 1.5 m/s. Doppler flow interrogations of TR and PR 148 
jets provided estimates of systolic and diastolic pulmonary artery pressure respectively, 149 
allowing diagnosis of PH and estimation of severity. A peak systolic TR flow velocity > 2.8 150 
m/s or a peak diastolic PR flow velocity ≥ 2.2 m/s was considered compatible with PH.16  151 
The modified Bernoulli equation was applied to the peak systolic TR and peak diastolic PR 152 
flow velocity to estimate systolic and diastolic pulmonary artery pressure.  153 
 154 
Statistical analysis 155 
All statistical analyses were performed using a commercially available software packageg and 156 
an alpha value of 0.05 was used throughout. Variables were assessed for normality by visual 157 
inspection of histograms and using Shapiro-Wilks tests. Parametrically and non-158 
parametrically distributed variables were compared using Student’s t test or Mann-Whitney U 159 
test, respectively. Categorical variables were compared using Fisher’s exact test or Chi square 160 
test. Data from parametric variables were presented as mean (± standard error), and those 161 
from non-parametric data were presented as median (± inter-quartile range (IQR)). Pearson 162 
correlation coefficients were calculated to determine whether RDW was correlated with age, 163 
haematocrit, mean corpuscular volume (MCV), total white blood cell count, platelet count, 164 
serum creatinine concentration, TR pressure gradient (TRPG), PR pressure gradient (PRPG) 165 
or ratio of left atrial to aortic root diameter (LA:Ao) in dogs with PH.      166 
 For the purpose of further analysis, cases with PH were divided into those with post-167 
capillary hypertension (due to left-sided cardiac disease) or pre-capillary hypertension (due to 168 
primary respiratory disease, idiopathic PH, or pulmonary vascular disease). Cases with PH 169 
were also divided according to the severity of the PH. Dogs with a peak systolic TRPG 170 
regurgitation pressure gradient of 31-50 mmHg were considered to have mild PH, dogs with 171 
a gradient of 51-75 mmHg were considered to have moderate PH and dogs with a gradient 172 
greater than 76 mmHg were considered to have severe PH.20   173 
 To determine whether RDW was a useful predictor of moderate or severe PH (TRPG 174 
> 50 mmHg), a receiver operator characteristic (ROC) curve was constructed using RDW 175 
values. The area under the curve was determined, and a suitable cut off value was chosen to 176 
estimate sensitivity and specificity values. 177 
 Dogs with PH were divided into balanced terciles according to RDW values (lowest 178 
to 15.7, 15.8 to 17.3 and 17.4 to highest). Average survival times were compared between 179 
these groups using Kaplan-Meier product limit estimates and log-rank test. This analysis was 180 
also conducted separately for dogs with known cardiorespiratory death. Dogs that were still 181 
alive at the study end point were censored. Similar survival analyses were also conducted to 182 
compare dogs with pre- and post-capillary PH and according to the severity of PH.   183 
     184 
Results  185 
Study populations   186 
Forty-four dogs were diagnosed with PH during the study period. The median age of affected 187 
dogs was 9.0 years (IQR, 4.3-11.4). The group was comprised of 18 intact males, 9 neutered 188 
males, 4 intact females and 13 neutered females. Twenty-five different breeds were 189 
represented, and the 5 most common were Jack Russell terrier (n=5), cross-breed (n=4), 190 
Border Collie (n=3), West Highland White terrier (n=3), and Yorkshire terrier (n=3).  191 
 The control group was composed of 79 dogs, of which 42 were blood donors and 37 192 
were dogs presented for problem investigation. The median age of this group was 2.9 years 193 
(IQR, 2.0–6.0), which was significantly lower than the median age of the dogs with PH (P < 194 
0.001). This group was composed of 18 intact males, 30 neutered males, 7 intact females and 195 
24 neutered females. Twenty-six different breeds were represented, and the most common 196 
were cross-breeds (n=17), Labrador retrievers (n=13), Golden retrievers (n=7), German 197 
Shepherd dogs (n=6), and English springer spaniels (n=4).  198 
 199 
Pulmonary hypertension  200 
All of the dogs diagnosed with PH had systolic TR flow velocities > 2.8 m/s, and PR flow 201 
velocities were > 2.2 m/s in 24/44 dogs in which it was present. The median TRPG in dogs 202 
with PH was 71.0 mmHg (IQR, 51.1-98.7; range, 37.5-238.8). Eleven dogs had mild PH, 14 203 
had moderate PH, and 19 had severe PH. Among the 24 dogs for which measurements were 204 
available, the median PRPG was 38.1 mmHg (IQR, 33.8-49.5; range, 14.4-63.4).      205 
 Twenty-eight dogs had pre-capillary PH caused by Angiostrongylus vasorum 206 
infestation (n=7), primary PH with no detected underlying cause (n=7), idiopathic pulmonary 207 
fibrosis (n=5), suspected or confirmed pulmonary thromboembolism (n=3), other 208 
parenchymal pulmonary disease (n=2), systemic-to-pulmonary shunt (n=4) including 2 dogs 209 
with right-to-left shunting patent ductus arteriosus. Sixteen dogs had post-capillary PH, 210 
caused by degenerative mitral valve disease (n=12), dilated cardiomyopathy (n=3), and aortic 211 
stenosis with systolic failure (n=1). The LA/Ao was significantly greater in dogs with post-212 
capillary PH compared to dogs with pre-capillary PH, and TRPG, PRPG and total white 213 
blood cell count were all significantly greater in dogs with pre-capillary PH (Table 1).  214 
 Once the diagnosis was established, dogs with PH were treated with one or more of 215 
the following drugs at the discretion of the attending clinician: angiotensin converting 216 
enzyme inhibitor (n=44), pimobendan (n=24), furosemide (n=16), fenbendazole (n=10), 217 
sildenafil (n=7), spironolactone (n=7), and atenolol (n=1).   218 
 219 
Red cell distribution width  220 
The median RDW in control dogs was 15.7% (IQR, 15.0-16.4; range, 13.5-18.3), which was 221 
significantly lower than in dogs with pre-capillary PH (16.3%; IQR, 15.6-17.9; range, 12.7-222 
19.6; P = 0.008) but not post-capillary PH (16.9; IQR, 15.0-17.6; range, 14.5-21.1; P = 223 
0.063). There was no difference in RDW between dogs with pre- and post-capillary PH (P = 224 
0.714). Distributions of RDW in each group are shown in Figure 1.   225 
 There was no difference in RDW between dogs with mild, moderate or severe PH 226 
(Fig. 2, P = 0.384). The area under the ROC curve constructed using RDW values for 227 
prediction of a TRPG value greater than 50 mmHg was 0.612 (95% confidence interval, 228 
0.429–0.794) (Fig. 3). Using a cut-off value of 15.9%, RDW had a sensitivity of 60.6% and 229 
specificity of 45.5% for differentiation of mild from moderate or severe PH. The RDW was 230 
significantly correlated with mean corpuscular volume (P < 0.001) and haematocrit (P = 231 
0.045) in dogs with PH but was not associated with LA:Ao, TRPG, PRPG, total white blood 232 
cell count, platelet count or serum creatinine concentration (Table 2).     233 
 234 
Survival times  235 
There was no significant difference in median survival times between dogs with PH divided 236 
into terciles according to RDW values (P = 0.071), though there was a trend for greater 237 
mortality with higher RDW values (Fig. 4A). Survival curves for dogs with PH stratified 238 
according to cause of PH and severity of peak systolic TR are shown in Figures 4B and 4C, 239 
respectively. There was no difference in survival between these groups (P = 0.948 and P = 240 
0.622, respectively).     241 
 242 
Discussion 243 
This study demonstrates that RDW differs significantly between dogs with pre-capillary PH 244 
and control dogs, but not between control dogs and those with post-capillary PH. There was 245 
no difference in survival between dogs grouped according to RDW values, and RDW was not 246 
a useful predictor of the severity of PH. The RDW was correlated with MCV and haematocrit 247 
in dogs with PH.    248 
 The findings presented here are in agreement with retrospective and prospective 249 
studies in human patients, which indicate that RDW can provide additional diagnostic 250 
information in patients with PH.24 In a recent study in dogs, RDW was significantly increased 251 
with pre-capillary PH compared to controls, but not in dogs with post-capillary PH,b similar 252 
to the findings of this study. There was no difference in RDW between healthy dogs and 253 
those with either compensated or decompensated heart failure due to degenerative mitral 254 
valve disease.25   255 
 The reasons for alteration in RDW in patients with PH remain unclear. Because RDW 256 
is an indicator of anisocytosis, it varies with iron deficiency anaemia, and iron status appears 257 
to be essential in the regulation of pulmonary vascular tone.26,27 In human patients, iron 258 
deficiency has been identified in idiopathic PH.28,29 In heart failure patients with post-259 
capillary PH, RDW is thought to be affected by chronic inflammation, renal dysfunction, 260 
altered erythropoiesis, and oxidative and nutritional stress.9,14,30 It is therefore likely that 261 
RDW is influenced by numerous factors involved in the pathogenesis of PH.  262 
Angiostrongylus vasorum infestation is known to cause variable effects on erythroid 263 
parameters,31,32 though, to the authors’ knowledge, RDW values have not been assessed in 264 
infected dogs.    265 
 Significant correlations between RDW and serum urea and creatinine concentration 266 
were previously reported in dogs with PH.b No such correlation was detected in the present 267 
study, but the relationship between RDW and serum urea and creatinine concentration in 268 
human patients with PH is contradictory, with one study showing a significant correlation 269 
with serum urea and a strong trend towards significance with serum creatinine15 whereas in 270 
other studies no such correlation was identified.13,14 Interestingly, in contrast to studies in 271 
human patients10,12 but in line with the canine study by Poser,b we found no significant 272 
correlation between RDW and peak TR or PR jet velocity, which may reflect differences in 273 
sample size between canine studies and the larger investigations in human patients. To date, 274 
the only circulating biomarker shown to be associated with peak TR gradient in dogs with PH 275 
is N-terminal pro-brain natriuretic peptide (NT-proBNP).20  The RDW was found to be 276 
significantly correlated with haematocrit and mean corpuscular volume in dogs with PH, as 277 
was also found in dogs with degenerative valve disease.25 278 
 The RDW has been shown to predict outcome in human patients with pre- and post-279 
capillary PH in numerous studies.10-15 In the present study however, RDW did not provide 280 
clinically useful prognostic information in dogs with PH. This result may reflect the small 281 
sample size of affected dogs, particularly as there was a trend towards increased mortality 282 
with higher RDW values as observed in people,15 or the influence of treatments such as 283 
furosemide, sildenafil and pimobendan instituted following diagnosis of PH. Studies in 284 
humans indicate incremental increases in serial RDW measurements are associated with 285 
decreased survival in heart failure33,34 therefore serial RDW measurements in dogs may be an 286 
area of future study. 287 
 A number of publications have explored the diagnostic utility of circulating 288 
biomarkers including natriuretic peptides and cardiac troponin I (cTnI) in dogs with pre- and 289 
post-capillary PH.19-22 One report indicated that measurement of circulating NT-proBNP but 290 
not N-terminal pro-atrial natriuretic peptide (NT-proANP) or cTnI was able to stratify dogs 291 
with pre-capillary PH into mild, moderate and severe.20 In an experimental canine model of 292 
pre-capillary PH, circulating NT-proANP and NT-proBNP could identify dogs with moderate 293 
and severe but not mild PH.19  In the present study, a trend was identified with increasing 294 
RDW values in dogs with moderate and severe PH, but this did not reach significance which 295 
may reflect the relatively small number of cases in each group.   296 
 In a study of 162 human patients of which 62% had pulmonary arterial hypertension, 297 
RDW was found to be independently associated with death in patients with severe PH and 298 
performed better as a prognostic indicator than NT-proBNP.15 The RDW was also shown to 299 
add significant prognostic value to measurements of NT-proBNP in human patients with 300 
idiopathic pulmonary hypertension.14 Unfortunately, in the retrospective report presented 301 
here, NT-proBNP data was not available and it was not possible to compare the ability of the 302 
two biomarkers to identify dogs with PH and predict survival.  303 
 The present study is the first to indicate that RDW, a simple parameter routinely 304 
measured as part of a haematological profile, may be useful in the diagnosis of dogs with PH 305 
with a number of different aetiologies. The sensitivity and specificity of RDW in the 306 
diagnosis of PH are based on the performance of the parameter in the whole study sample. It 307 
is clear for our results that some overlap in RDW values occurs between the control 308 
population and dogs with pre-capillary PH, which suggests that RDW may not be a useful 309 
parameter for determining the disease status of single individuals. The performance of a 310 
screening test depends not only on its intrinsic ability to identify affected individuals but also 311 
on the prevalence of disease within the population. In this retrospective study, populations 312 
were preselected on the basis of the presence of confirmed PH or control dogs representing 313 
groups with 100% or 0% disease prevalence, respectively. Under these circumstances, a 314 
screening test is likely to exhibit superior performance than would the same test used in a 315 
more heterogeneous population encountered in the clinic. Furthermore, RDW may be 316 
increased due to other pathological processes, so this indicator may also lack specificity in 317 
clinical settings. Further studies will be required to determine whether RDW values may 318 
contribute useful prognostic information, as they do in humans.    319 
 This study has a number of limitations as a result of its retrospective nature. Due to 320 
the strict inclusion criteria, the study population of affected animals was small which reduces 321 
statistical power. The study was not designed to assess the influence of different treatments 322 
for dog with pre- and post-capillary PH on survival or RDW. Affected dogs with PH were 323 
significantly older than the control population. An age related increase in red blood cell 324 
membrane stability and RDW has been reported in women35 but no information is available 325 
for dogs. The RDW was assessed as a single prognostic factor in the present study as the 326 
small sample size and low event (mortality) rate within the study period precluded more 327 
sophisticated analysis, such as Cox proportional hazards regression. Future studies of a larger 328 
size will be required to establish whether the prognostic value of this parameter is altered 329 
after other variables have been accounted for. The retrospective nature of the study meant 330 
that patient and control RDW values were obtained from a Cell-Dyn 3500, although the 331 
majority of the human literature refers to more recent haematology analyser models. 332 
Prospective studies using newer generation analysers may provide better discrimination for 333 
RDW value prognostication.    334 
 The results of this study show that RDW differed significantly between dogs with pre-335 
capillary PH and control dogs, but RDW was not a significant prognostic marker in dogs with 336 
PH. Further studies will be required to determine whether RDW has prognostic significance 337 
in larger groups of dogs with PH, or in dogs with other forms of cardiorespiratory disease.    338 
 339 
  340 
Footnotes 341 
a Cell-Dyn 3500 System Operators Manual, Abbott Laboratories, Abbott Park, Illinois, USA.. 342 
b Poser H, Mazzotta E, Menciotti G, Contiero B, Baron Toaldo M, Guglielmini C. Red blood 343 
cell distribution width in dogs with pre-capillary and post-capillary pulmonary hypertension.  344 
Poster presented at the 23rd ECVIM-CA Congress, Liverpool, UK, September 2013.  345 
c RVC Diagnostic Laboratories, Royal Veterinary College, London, UK. 346 
d ILab600 Instrumentation Laboratory, Werfen Life Group, Barcelona, Spain. 347 
e GE Vivid 7, GE Healthcare, Hatfield, UK  348 
f GE EchoPAC PC, GE Healthcare, Hatfield, UK. 349 
g IBM SPSS Statistics for Windows, Version 20.0, Released 2011, IBM Corp. Armonk, NY, 350 
USA. 351 
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  476 
Figure Legends 477 
Figure 1: Red cell distribution width values in control dogs and dogs with pre-capillary or 478 
post-capillary pulmonary hypertension. Lines represent the median for each group.  479 
 480 
  481 
Figure 2: Red cell distribution width values in control dogs and dogs with mild, moderate 482 
and severe  pulmonary hypertension defined by peak systolic tricuspid regurgitant pressure 483 
gradient. Lines represent the median for each group.   484 
 485 
  486 
Figure 3: Receiver operator characteristic curve constructed to determine whether red cell 487 
distribution width values can predict mild (peak systolic tricuspid regurgitant pressure 488 
gradient < 50 mmHg) or moderate to severe (peak systolic tricuspid regurgitant pressure 489 
gradient ≥ 50 mmHg) pulmonary hypertension. 490 
 491 
 492 
  493 
Figure 4: Kaplan-Meier survival curve in dogs with (A) pulmonary hypertension divided into 494 
terciles according to red cell distribution width values: lowest value to 15.7 (solid line), 15.8 495 
to17.3 (dotted line), 17.4 to highest (dashed line), (B) pre-capillary pulmonary hypertension 496 
(dotted line) or post-capillary pulmonary hypertension (solid line), and (C) mild (solid line), 497 
moderate (dotted line) and severe pulmonary hypertension (dashed line). Tick marks indicate 498 
censored cases. 499 
 500 
  501 
Table 1: Echocardiographic, haematological and biochemical variables in dogs with pre-502 
capillary and post-capillary pulmonary hypertension and control dogs. P values represent 503 
comparison between dogs with pre-capillary and post-capillary pulmonary hypertension. 504 
Parameter Pre-capillary PHa 
(median, IQRb) 
Post-capillary 
PHa (median, 
IQRb) 
P value Control 
LA:Aoc ratio 1.33 (1.13-1.55) 2.21 (1.16-1.54) <0.001  
TRPGd (mmHg) 80.4 (56.3-108.8) 52.5 (43.2-70.8) 0.001  
PRPGe (mmHg) 40.1 (34.9-52.1) 33.9 (22.3-38.5) 0.040  
RDWf (%) 16.3 (15.6-17.9) 16.9 (15.0-17.6) 0.714 15.6 (15.0-16.2) 
Haematocrit (%) 43.7 (39.0–49.5) 47.6 (43.7–50.9) 0.205 46.8 (44.5-50.0) 
MCVg (µl) 69.1 (66.8–71.1) 70.7 (68.7–71.7) 0.317 71.5 (70.1-73.8) 
WBCCh (x109/l) 16.2 (11.2-19.8) 10.6 (8.3-12.8) 0.010 9.3 (8.2-10.4) 
Platelet count 
(x109/l) 
302 (187-377) 290 (227-519) 0.317 229 (193-260) 
Serum creatinine 
concentration 
(µmol/l) 
93.0 (81.0-120.5) 108.5 (90.8-
120.0) 
0.432 104.0 (95.0-
119.0) 
PH, pulmonary hypertension; IQR, inter-quartile range; LA/Ao, ratio of left atrial to aortic 505 
root diameter; TRPG, peak systolic tricuspid regurgitation pressure gradient; PRPG, peak 506 
diastolic pulmonic regurgitation pressure gradient; RDW, red cell distribution width; MCV, 507 
mean corpuscular volume; WBCC, total white blood cell count. 508 
  509 
Table 2: Results of correlations between red cell distribution width and clinical pathological 510 
variables in dogs with pulmonary hypertension. 511 
Variable Correlation coefficient P value 
Age (years) -0.249 0.103 
LA:Aoa 0.054 0.777 
TRPGb 0.113 0.465 
PRPGc -0.020 0.927 
Haematocrit 0.304 0.045 
MCVd -0.664 <0.001 
WBCCe -0.066 0.668 
Platelet count -0.268 0.079 
Serum creatinine concentration 0.147 0.385 
LA/Ao, ratio of left atrial to aortic root diameter; TRPG, peak systolic tricuspid regurgitation 512 
pressure gradient; PRPG, peak diastolic pulmonic regurgitation pressure gradient; RDW, red 513 
cell distribution width; MCV, mean corpuscular volume; WBCC, total white blood cell 514 
count. 515 
